Desloratadine-Eudragit® RS100 Nanoparticles: Formulation and Characterization

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2017, Vol 14, Issue 2

Abstract

Objectives: The objective of the present study was to formulate Desloratadine-Eudragit® RS100 nanoparticles and investigate the characteristics of the prepared nanoparticles. Materials and Methods: The nanoparticles were prepared by spray drying method and the quantification of desloratadine (DL) was carried out with a high performance liquid chromatography (HPLC) method. Results: DL was successfully loaded to polymer and the developed HPLC method was found to be linear, reproducible, precise, accurate, specific and selective. Characterization of the nanoparticles including entrapment efficiency, particle size, zeta potential, morphology, polidispersity index, solid state characterizations and drug release was performed. In vitro release studies of DL loaded nanoparticles were also examined in the simulated intestinal fluid (pH 7.4). In vitro release of DL from nanoparticle formulations followed Korsemeyer-Peppas model. Conclusion: A validated HPLC method was developed for the determination of DL. Proposed spray drying method can be successfully applicable to the nanoparticle preparation containing DL. In addition, the release studies of all nanoparticles and active substance have been studied comparatively. Hence, it could be concluded that DL loaded nanoparticles seem to be a promising drug delivery system for the active agent.

Authors and Affiliations

Evrim YENİLMEZ

Keywords

Related Articles

Subcutaneous Toxicity of Agmatine in Rats

Objectives: The aim of this study was to investigate the effects of repetitive agmatine administration on sensorimotor gating in rats first but, as unexpected, ulcerative necrotic cutaneous lesions appeared, thus, the st...

In Vitro Macrophage Nitric Oxide and Interleukin-1 Beta Suppression by Moringa peregrina Seed

Objectives: Moringa peregrina has long been used in folk medicine to treat diseases including fever, headache, burns, constipation, gut pains, and inflammation. Nitric oxide (NO) and interleukin-1β (IL-1β) play an import...

Desloratadine-Eudragit® RS100 Nanoparticles: Formulation and Characterization

Objectives: The objective of the present study was to formulate Desloratadine-Eudragit® RS100 nanoparticles and investigate the characteristics of the prepared nanoparticles. Materials and Methods: The nanoparticles wer...

Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and In Vitro Evaluation

Objectives: To design a formulation and develop ODTs of AMB hydrochloride and salbutamol sulphate in combination for the treatment of respiratory disorders and perform an in vitro evaluation using superdisintegrants in c...

Structure Elucidation and Antimicrobial Activities of Secondary Metabolites from the Flowery Parts of Verbascum mucronatum Lam.

Objectives: To determine the secondary metabolites from Verbascum mucronatum Lam. and evaluate their antimicrobial activity. Materials and Methods: Antimicrobial activities of the isolated metabolites were determined usi...

Download PDF file
  • EP ID EP380965
  • DOI 10.4274/tjps.52523
  • Views 121
  • Downloads 0

How To Cite

Evrim YENİLMEZ (2017). Desloratadine-Eudragit® RS100 Nanoparticles: Formulation and Characterization. Turkish Journal of Pharmaceutical Sciences, 14(2), 148-156. https://europub.co.uk/articles/-A-380965